Anti-Toxoplasma gondii antibodies in patients with schizophrenia - Preliminary findings in a Turkish sample

78Citations
Citations of this article
81Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Schizophrenia is a serious neuropsychiatric disease of uncertain etiology. We investigated the seropositivity rate for anti-Toxoplasma IgG and IgM antibodies by enzyme-linked immunosorbent assay (ELISA) in patients with schizophrenia to ascertain a possible relationship between Toxoplasma gondii and schizophrenia. We selected 100 patients with schizophrenia, 50 with depressive disorder, and 50 healthy volunteers to investigate the seropositivity rate of anti-Toxoplasma antibodies by ELISA. The seropositivity rate for anti-Toxoplasma IgG antibodies among schizophrenia patients (66%) was significantly higher than among patients with depressive disorder or healthy volunteers (P < .01). Thus, there might be a causal relationship between toxoplasmosis and the etiology of schizophrenia. © The Author 2007. Published by Oxford University Press on behalf of the Maryland Psychiatric Research Center. All rights reserved.

Author supplied keywords

Cite

CITATION STYLE

APA

Cetinkaya, Z., Yazar, S., Gecici, O., & Namli, M. N. (2007). Anti-Toxoplasma gondii antibodies in patients with schizophrenia - Preliminary findings in a Turkish sample. Schizophrenia Bulletin, 33(3), 789–791. https://doi.org/10.1093/schbul/sbm021

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free